SCHEMBL1743516

SCHEMBL1743516

COC(=O)C=CC(NC(=O)OC(C)(C)C)C(O[Si](C)(C)C(C)(C)C)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
CYP26A1 O43174 1/20 0.31
NOS3 P29474 2/20 0.31
NOS1 P29475 2/20 0.31
NOS2 P35228 2/20 0.31
CTSL P07711 1/20 0.31
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31
PDE2A O00408 2/20 0.31
CES2 O00748 1/20 0.30
CES1 P23141 1/20 0.30
AAK1 Q2M2I8 1/20 0.30
ABCB1 P08183 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRB2 P47870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12241676 1.00 PPARG (0.38) PPARGPPARAMAPTALDH1A1LMNA
SCHEMBL1743514 1.00 PPARG (0.38) PPARGPPARAMAPTALDH1A1LMNA
SCHEMBL1743518 1.00 PPARG (0.38) PPARGPPARAMAPTALDH1A1LMNA
SCHEMBL1741901 0.91 PPARA (0.41) PPARGPPARAMAPTALDH1A1LMNA
SCHEMBL1741902 0.91 PPARA (0.41) PPARGPPARAMAPTALDH1A1LMNA
SCHEMBL12706285 0.81 PPARG (0.41) PPARGPPARAPDE2ACES2CES1
SCHEMBL12241677 0.81 PPARG (0.39) PPARGPPARACYP26A1NOS3NOS1
SCHEMBL1742055 0.81 PPARG (0.39) PPARGPPARACYP26A1NOS3NOS1
SCHEMBL1742052 0.81 PPARG (0.39) PPARGPPARACYP26A1NOS3NOS1
SCHEMBL5019017 0.79 PPARG (0.44) PPARGPPARACYP26A1CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387570-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE Amgen, Inc (US) 2011-11-23 EP disclosed
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2011-10-27 US disclosed
WO-2010083246-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263647-A1 FLUOROISOQUINOLINE SUBSTITUTED THIAZOLE COMPOUNDS AND METHODS OF USE TFEB, PCK2, JAK2 PPARG 232/4885PPARA 896/4885MAPT 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.